|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received October 8, 2007
Accepted on February 1, 2008
ORIGINAL ARTICLES |
,
,
,
,
,
1
*Renal, Electrolyte and Hypertension Division of the Department of Medicine,
Center for Clinical Epidemiology and Biostatistics, and
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and
Winthrop University Hospital, Mineola, New York
1 To whom correspondence should be addressed. E-mail: hfeldman{at}mail.med.upenn.edu.
| Abstract |
|---|
Background and objectives: Hemoglobin variability is common among dialysis patients, and has been associated with increased mortality. The causal nature of this association has been difficult to ascertain because of potential time-dependent confounding, for which traditional statistical methods do not control.
Design, settings, participants, & measurements: A retrospective cohort of 34,963 Fresenius Medical care dialysis patients from 1996 was assembled. Hemoglobin variability, absolute hemoglobin level, and temporal hemoglobin trend were measured over rolling 6-mo exposure windows. Their association with mortality was estimated using history-adjusted marginal structural analysis that adjusts for time-dependent confounding by applying weights to observations inversely related to the predictability of observed levels of hemoglobin.
Results: In the primary analysis, each g/dl increase in hemoglobin variability was associated with an adjusted hazard ratio (HR) [95% confidence interval (CI)] for all-cause mortality of 1.93 (1.20 to 3.10). Neither higher absolute hemoglobin level nor increasing hemoglobin trend were significantly associated with mortality; adjusted HR (95% CI) 0.85 (0.64 to 1.11) and 0.60 (0.25 to 1.45), respectively.
Conclusions: Marginal structural analysis demonstrates that hemoglobin variability is associated with increased mortality among chronic hemodialysis patients, and that this effect is more pronounced than appreciated using standard statistical techniques that do not take time-dependent confounding into account.
This article has been cited by other articles:
![]() |
T. V. Glotzer, E. G. Daoud, D. G. Wyse, D. E. Singer, M. D. Ezekowitz, C. Hilker, C. Miller, D. Qi, and P. D. Ziegler The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 474 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besarab, W. H. Horl, and D. Silverberg Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome Oncologist, September 1, 2009; 14(suppl_1): 22 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Boudville, O. Djurdjev, I. C. Macdougall, A. L.M. de Francisco, G. Deray, A. Besarab, P. E. Stevens, R. G. Walker, P. Urena, P. Inigo, et al. Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Arneson, D. Zaun, Y. Peng, C. A. Solid, S. Dunning, and D. T. Gilbertson Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1378 - 1383. [Full Text] [PDF] |
||||
![]() |
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Brunelli, K. E. Lynch, E. D. Ankers, M. M. Joffe, W. Yang, R. I. Thadhani, and H. I. Feldman Association of Hemoglobin Variability and Mortality among Contemporary Incident Hemodialysis Patients Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1733 - 1740. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |